Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

1-(N-(2-methoxybenzyl)acetylamino)-3-(1H-indol-3-yl)-2-(N-(2-(4-(piperidin-1-yl)piperidin-1-yl)acetyl)amino)propane MeSH Supplementary Concept Data 2025


MeSH Supplementary
1-(N-(2-methoxybenzyl)acetylamino)-3-(1H-indol-3-yl)-2-(N-(2-(4-(piperidin-1-yl)piperidin-1-yl)acetyl)amino)propane
Unique ID
C096759
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C096759
Entry Term(s)
LY 303870
LY 306155
LY-303870
LY-306155
LY303870
LY306155
Lanepitant
Pharm Action
Neurokinin-1 Receptor Antagonists
Registry Numbers
0
17G8FN2E1F
Related Numbers
17G8FN2E1F
Heading Mapped to
*Indoles
*Piperidines
Frequency
31
Note
a selective nonpeptide Substance P (neurokinin-1) receptor antagonist; structure given in first source
Source
J Pharmacol Exp Ther 1995 Nov;275(2):737-44
Date of Entry
1995/12/18
Revision Date
2014/07/29
1-(N-(2-methoxybenzyl)acetylamino)-3-(1H-indol-3-yl)-2-(N-(2-(4-(piperidin-1-yl)piperidin-1-yl)acetyl)amino)propane Preferred
LY 306155 Narrower
Lanepitant Narrower
LY 303870 Narrower
page delivered in 0.005s